- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT07616518
Dynamic Trajectories of Pupillary Light Reflex Parameters and Prognosis in Critically Ill Patients: A Multicenter Prospective Cohort Study (PUPIL)
Studienübersicht
Status
Bedingungen
Detaillierte Beschreibung
Critically ill patients admitted to emergency intensive care units often have complex underlying conditions, rapid changes in disease severity, fluctuating organ function, and multiple therapeutic influences. Conventional assessment tools, including vital signs, Glasgow Coma Scale, RASS, CPOT, APACHE II, laboratory tests, and imaging examinations, are important in clinical practice but may be limited by subjectivity, intermittent availability, or reduced reliability in patients receiving sedation, analgesia, mechanical ventilation, or organ support.
The pupillary light reflex is a classic component of neurological examination. Automated quantitative pupillometry provides objective and reproducible measurements of pupillary light reflex parameters, including pupil diameter, constriction velocity, dilation velocity, constriction percentage, maximum constriction velocity, and latency. These parameters may reflect brainstem reflex function, autonomic nervous system activity, medication effects, pain, circulatory status, and systemic stress responses in critically ill patients.
This study will enroll adult critically ill patients admitted to participating emergency intensive care units. After written informed consent is obtained from the participant or a legally authorized representative, baseline demographic data, primary diagnosis, disease severity scores, treatment information, organ support, sedation and analgesia status, vasoactive medication use, and vital signs will be collected. Pupillary light reflex parameters will be measured using a handheld automated quantitative pupillometer once daily during the first 7 days after EICU admission, or until EICU discharge or death, whichever occurs first. Additional measurements may be performed when clinically indicated.
The primary analysis will focus on the dynamic trajectory of constriction velocity during the early EICU period. Dilation velocity, pupil diameter, constriction percentage, maximum constriction velocity, and latency will be analyzed as supplementary pupillary light reflex parameters. Group-based trajectory modeling will be used to identify distinct longitudinal trajectory patterns of pupillary light reflex parameters.
The primary outcome is 90-day functional outcome assessed by the Glasgow Outcome Scale-Extended. Unfavorable functional outcome is defined as a GOS-E score of 4 or lower, and death during follow-up will be included in the GOS-E scoring system. The secondary outcome is discharge outcome, which will be analyzed primarily as a binary outcome. Favorable discharge outcome is defined as discharge home or transfer to a rehabilitation facility. Unfavorable discharge outcome is defined as in-hospital death, discharge to hospice or long-term care facility, or discharge against medical advice. Transfer to a higher-level hospital or another medical institution for continued treatment will be recorded as an indeterminate disposition and further followed when feasible.
This study will further evaluate whether dynamic trajectories of pupillary light reflex parameters provide additional prognostic value beyond conventional static measurements and clinical variables. No treatment assignment or intervention will be performed as part of this study. All clinical management decisions will be made by the treating physicians according to routine clinical practice.
Studientyp
Einschreibung (Geschätzt)
Kontakte und Standorte
Studienkontakt
- Name: Danni Jin, MD
- Telefonnummer: +8615825512455
- E-Mail: 670251925@qq.com
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
- Erwachsene
- Älterer Erwachsener
Akzeptiert gesunde Freiwillige
Probenahmeverfahren
Studienpopulation
Beschreibung
Inclusion Criteria:
- Age 18 years or older.
- Admission to the emergency intensive care unit.
- Critically ill patients with an expected EICU stay longer than 48 hours.
- Written informed consent obtained from the participant or legally authorized representative.
Exclusion Criteria:
- Severe ocular disease, severe ocular trauma, postoperative ocular status, or other conditions that prevent reliable pupillary measurement.
- Known neuro-ophthalmic disorders that may affect the pupillary light reflex, such as oculomotor nerve palsy.
- Use of topical ophthalmic medications during the study period that may significantly affect pupillary response, when their effects cannot be accurately recorded or evaluated.
- Pregnancy or breastfeeding.
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
Kohorten und Interventionen
Gruppe / Kohorte |
|---|
|
Adult critically ill patients admitted to the EICU
Adult critically ill patients admitted to emergency intensive care units who meet the eligibility criteria will be enrolled in a single prospective observational cohort.
Participants will undergo quantitative pupillometry during the first 7 days after EICU admission, or until EICU discharge or death, whichever occurs first.
Clinical information, treatment data, discharge outcome, and 90-day functional outcome will be collected.
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
90-Day Functional Outcome Assessed by the Glasgow Outcome Scale-Extended
Zeitfenster: 90 days after disease onset
|
Functional outcome will be assessed using the Glasgow Outcome Scale-Extended at 90 days after disease onset.
Unfavorable functional outcome is defined as a GOS-E score of 4 or lower.
Participants who die during follow-up will be included in the GOS-E scoring system, and the 90-day mortality rate will be reported separately.
|
90 days after disease onset
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Discharge Outcome
Zeitfenster: From EICU admission to hospital discharge; indeterminate transfers will be followed up to 90 days when feasible
|
Discharge outcome will be analyzed primarily as a binary outcome: favorable versus unfavorable discharge outcome.
Favorable discharge outcome is defined as discharge home or transfer to a rehabilitation facility.
Unfavorable discharge outcome is defined as in-hospital death, discharge to hospice, transfer to a long-term care facility, or discharge against medical advice.
Transfer to a higher-level hospital or another medical institution for continued treatment will be recorded as an indeterminate disposition and further followed when feasible.
|
From EICU admission to hospital discharge; indeterminate transfers will be followed up to 90 days when feasible
|
Mitarbeiter und Ermittler
Mitarbeiter
Ermittler
- Hauptermittler: Mao Zhang, MD, Second Affiliated Hospital, School of Medicine, Zhejiang University
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Geschätzt)
Primärer Abschluss (Geschätzt)
Studienabschluss (Geschätzt)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- 20260245
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Beschreibung des IPD-Plans
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur Kritische Krankheit
-
Yancheng First People's HospitalNoch keine RekrutierungCritical Illness; Mechanical Ventilation; Schock
-
Charite University, Berlin, GermanyReactive Robotics GmbHAbgeschlossenKritische Krankheit | Rehabilitation | Frühe Gehfähigkeit | Critical Illness PolyneuromyopathieDeutschland
-
Adana City Training and Research HospitalAbgeschlossenCritical Illness PolyneuromyopathieTruthahn
-
Istituto Clinico HumanitasRekrutierungKritische Krankheit Myopathie | Kritische Krankheit Polyneuropathie | Critical Illness PolyneuromyopathieItalien
-
University of AthensUnbekanntCritical-Illness-Polyneuromyopathie (CIPNM) | Auf der Intensivstation erworbene Schwäche (ICUAW)Griechenland
-
Hospital de Clinicas de Porto AlegreUnbekanntCritical Illness PolyneuropathienBrasilien
-
Charite University, Berlin, GermanyReactive Robotics GmbHAbgeschlossenKritische Krankheit | Covid19 | Rehabilitation | Robotik | Frühmobilisierung | Critical Illness PolyneuromyopathieDeutschland
-
Insel Gruppe AG, University Hospital BernMonash UniversityAktiv, nicht rekrutierendMuskelschwäche | Kritische Krankheit Myopathie | Physische Inaktivität | Kritische Krankheit Polyneuropathie | Critical Illness PolyneuromyopathieAustralien, Schweiz
-
Istituti Clinici Scientifici Maugeri SpAFondazione Don Carlo Gnocchi Onlus; Azienda Ospedaliero-Universitaria di Modena und andere MitarbeiterRekrutierungKritische Krankheit Myopathie | Critical-Illness-Polyneuromyopathie (CIPNM) | Guillain Barre-SyndromItalien
-
Koç UniversityAbgeschlossenCOVID-19 | Rehabilitation | Akutes Lungenversagen | Erworbene Schwäche auf der Intensivstation | Critical Illness PolyneuromyopathieTruthahn